FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077824 [Registered on: 09/12/2024] Trial Registered Prospectively
Last Modified On: 05/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   In Cases Of Severe And Moderate Ulcerative Colitis patients endoscopic and histological changes to be evaluated at first presentation 6 weeks and 6 months and correlation among these changes  
Scientific Title of Study   Evolution Of Endoscopic Lesions And Histological Indices In Cases Of Severe And Moderate Ulcerative Colitis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Soham Bhaumik 
Designation  MEDICAL GASTROENTEROLOGY DM RESIDENT 
Affiliation  Institute of Post Graduate Medical Education and Research 
Address  RONALD ROSS BUILDING 5TH FLOOR SCHOOL OF DIGESTIVE AND LIVER DISEASE DEPARTMENT OF GASTROENTEROLOGY Institute of Post Graduate Medical Education and Research District KOLKATA
54 RASHBIHARI SARANI HAKIMPARA SILIGURI
Darjiling
WEST BENGAL
700020
India 
Phone  8910442298  
Fax    
Email  sohambhaumik1990@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rajib Sarkar 
Designation  Associate Professor  
Affiliation  Institute of Post Graduate Medical Education and Research 
Address  RONALD ROSS BUILDING 5TH FLOOR SCHOOL OF DIGESTIVE AND LIVER DISEASE DEPARTMENT OF GASTROENTEROLOGY Institute of Post Graduate Medical Education and Research DISTRICT KOLKATA
Subhaspally Madhyamgram
North Twentyfour Parganas
WEST BENGAL
700020
India 
Phone  9477371103  
Fax    
Email  rajjoy5661@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Soham Bhaumik 
Designation  MEDICAL GASTROENTEROLOGY DM RESIDENT 
Affiliation  Institute of Post Graduate Medical Education and Research 
Address  RONALD ROSS-5TH FLOOR SCHOOL OF DIGESTIVE AND LIVER DISEASE DEPARTMENT OF GASTROENTEROLOGY Institute of Post Graduate Medical Education and Research DISTRICT-KOLKATA
54 RASHBIHARI SARANI HAKIMPARA SILIGURI
Darjiling
WEST BENGAL
700020
India 
Phone  8910442298  
Fax    
Email  sohambhaumik1990@gmail.com  
 
Source of Monetary or Material Support  
Institute of Post Graduate Medical Education and Research 
 
Primary Sponsor  
Name  Institute of Post Graduate Medical Education and Research 
Address  RONALD ROSS BUILDING 5TH FLOOR SCHOOL OF DIGESTIVE AND LIVER DISEASE IPGMER AND SSKM HOSPITAL KOLKATA 20 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Soham Bhaumik  Institute of Post Graduate Medical Education and Research  RONALD ROSS BUILDING 5TH FLOOR SCHOOL OF DIGESTIVE AND LIVER DISEASE DEPARTMENT OF GASTROENTEROLOGY 244 AJC BOSE ROAD KOLKATA 700020
Kolkata
WEST BENGAL 
8910442298

sohambhaumik1990@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,IPGMER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K518||Other ulcerative colitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  59.00 Year(s)
Gender  Both 
Details  Acute Severe ulcerative colitis who fulfil the Truelove and Witts criteria
Moderate and Severe ulcerative Colitis according to PMS Score or Mayo Score
Patients started on immunomodulators Azathioprine Infliximab Tofacitinib less than 6 weeks before inclusion
Patients who give consent to comply with follow up investigations and the treatment schedule
 
 
ExclusionCriteria 
Details  Acute severe Ulcerative Colitis who required Colectomy in their index presentation
Loss of follow up
Patients with contraindications to all the three drugs-Azathioprine Infliximab and tofacitinib
Patients who do not give consent
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the time course of Clinical and Endoscopic Scores following the baseline presentation in moderate and severe UC patients  To study the time course at first presentation then at 6 weeks then at 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
To study the time course of Histological Index following the baseline presentation
To correlate among the Clinical Endoscopic & Histological scores over the given time period
To determine the predictors of relapse at 6 months following index presentation of this cohort of UC patients
 
To study the time course at first presentation then at 6 weeks then at 6 months 
 
Target Sample Size   Total Sample Size="368"
Sample Size from India="368" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
   In this study we will assess the baseline clinical severity and mucosal involvement using endoscopy and histology in patients of Severe and Moderate Ulcerative Colitis at baseline and reassess the Endoscopic and Histological activity achieved at the end of 6 weeks and 6 months by using the composite score of validated Endoscopic scores and Histologic Indices in School of Digestive and Liver Disease Department of Gastroenterology IPGMER & SSKM Hospital
 
Close